News stories about CVS Health Corporation (NYSE:CVS) have trended somewhat positive this week, AlphaOne Sentiment reports. The research group, a division of Accern, scores the sentiment of news coverage by monitoring more than 20 million news and blog sources in real-time. AlphaOne ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. CVS Health Corporation earned a media sentiment score of 0.19 on AlphaOne’s scale. AlphaOne also gave press coverage about the pharmacy operator an impact score of 84 out of 100, indicating that recent news coverage is very likely to have an effect on the stock’s share price in the near future.
These are some of the news stories that may have impacted AlphaOne Sentiment’s analysis:
- Let’s have a look at recent traded volume CVS Health Corporation (CVS) stock – Stocks Gallery (stocksgallery.com)
- Pennsylvania Trust Co Cut Cvs Health Corp (CVS) Position by $3.16 Million – Weekly Register (weeklyregister.com)
- CVS & Walgreens: Are Pharmacies in Amazon’s Crosshairs? (finance.yahoo.com)
- Amazon destroys $28.5B of competitors' stock wealth after Whole Foods buy (finance.yahoo.com)
- CVS Health Corporation’s (CVS) Outperform Rating Reaffirmed at Cowen and Company (americanbankingnews.com)
CVS has been the topic of several recent research reports. Bank of America Corporation restated a “buy” rating and set a $106.67 target price on shares of CVS Health Corporation in a report on Tuesday, February 28th. Vetr lowered CVS Health Corporation from a “hold” rating to a “sell” rating and set a $76.18 target price on the stock. in a report on Tuesday, February 28th. Leerink Swann set a $90.00 target price on CVS Health Corporation and gave the company a “buy” rating in a report on Saturday, March 18th. Guggenheim restated a “buy” rating and set a $90.00 target price on shares of CVS Health Corporation in a report on Tuesday, March 28th. Finally, Jefferies Group LLC set a $82.00 target price on CVS Health Corporation and gave the company a “hold” rating in a report on Saturday, April 1st. Eight analysts have rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. CVS Health Corporation has a consensus rating of “Buy” and a consensus target price of $93.98.
CVS Health Corporation (CVS) traded up 1.35% during midday trading on Monday, reaching $78.10. The company had a trading volume of 5,949,547 shares. The firm has a market capitalization of $79.57 billion, a P/E ratio of 16.29 and a beta of 0.92. The stock’s 50 day moving average price is $78.96 and its 200-day moving average price is $79.32. CVS Health Corporation has a one year low of $69.30 and a one year high of $98.66. CVS Health Corporation also was the recipient of some unusual options trading activity on Friday. Stock investors acquired 1,498 put options on the company. This represents an increase of approximately 470% compared to the average volume of 263 put options.
CVS Health Corporation (NYSE:CVS) last issued its earnings results on Tuesday, May 2nd. The pharmacy operator reported $1.17 earnings per share for the quarter, beating analysts’ consensus estimates of $1.10 by $0.07. CVS Health Corporation had a net margin of 2.86% and a return on equity of 17.56%. The firm had revenue of $44.51 billion for the quarter, compared to analyst estimates of $44.20 billion. During the same quarter last year, the business posted $1.18 earnings per share. The company’s quarterly revenue was up 3.0% on a year-over-year basis. On average, equities research analysts anticipate that CVS Health Corporation will post $5.87 earnings per share for the current year.
In other CVS Health Corporation news, CFO David M. Denton sold 230,510 shares of the firm’s stock in a transaction that occurred on Monday, June 12th. The shares were sold at an average price of $80.00, for a total value of $18,440,800.00. Following the sale, the chief financial officer now owns 176,983 shares in the company, valued at $14,158,640. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, EVP Troyen A. Brennan sold 23,849 shares of the firm’s stock in a transaction that occurred on Tuesday, March 21st. The shares were sold at an average price of $78.73, for a total transaction of $1,877,631.77. Following the completion of the sale, the executive vice president now owns 94,309 shares in the company, valued at approximately $7,424,947.57. The disclosure for this sale can be found here. Company insiders own 0.61% of the company’s stock.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related companies with our FREE daily email newsletter.